HUBLO acquired by FIVE ARROWS
Context
Hublo enters a new phase of its development by welcoming Five Arrows as its new lead shareholder. This transaction marks a transition from Venture Capital to Private Equity (Primary LBO). The entry of Five Arrows aims to provide Hublo with the strategic and financial resources to consolidate its leadership in France and accelerate its expansion in Europe, particularly in Germany and Northern Europe. The partnership will focus on product innovation (AI integration for planning) and potential strategic acquisitions to build a comprehensive HR platform for the healthcare sector.
HUBLO, which reported an EBITDA margin of in 2024, is valued in this transaction at an EV/EBITDA multiple of , a level to compare with the average currently observed in the Healthcare & Pharma sector (14.3x).
-> Deep-dive in Healthcare & Pharma market trends
Target
A leading European digital platform for healthcare workforce management. Hublo helps hospitals, nursing homes, and clinics manage their internal and external staff replacements efficiently. By automating the recruitment and mobilization process of temporary workers and internal pools, it addresses the critical shortage of healthcare professionals. It serves over 3,500 facilities and 800,000 healthcare professionals in Europe (France and Germany).
Ent. Value
Equity Value
Multiples
EV / Revenue
EV / EBITDA
EV / EBIT
Historical Financials (EUR)
Similar deals in Healthcare Services
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 11/2025 | ASKER HEALTHCARE GROUP | FINMED GROUP | FRANCE | Hospital Logistics |
| 10/2025 | EVOLEM | APPERTON | FRANCE | Sterilization & Hygiene |
| 04/2025 | TRANSCARENT | ACCOLADE | UNITED STATES | Health Tech |
| 04/2025 | KERSIA | NEOGEN (ANIMAL BIOSECURITY DIVISION) | UNITED STATES | Sterilization & Hygiene |
| 10/2024 | Fullscript | Rupa Health | UNITED STATES | Health Tech |
| 07/2024 | ARDIAN | MASCO GROUP | ITALY | Healthcare Services |
| 06/2024 | PERMIRA | PHARMACORD | UNITED STATES | Health Tech |
| 05/2024 | 21 INVEST / OAKLEY CAPITAL INVESTMENTS | PRODUCT LIFE | FRANCE | Healthcare Services |
| 10/2023 | MOTION EQUITY PARTNERS | BANOOK | FRANCE | CRO / Clinical Trials |
| 09/2023 | PERMIRA | ERGOMED | UNITED KINGDOM | CRO / Clinical Trials |
REFERENCES
Valuation range: EV 100M - 350M EUR
Revenue range: 25M - 50M EUR
Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of HUBLO by FIVE ARROWS are reserved for mynth community members. Register for free to unlock full data.
Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.
Target: hublo
Acquirer: five arrows